Search This Blog

468x60.

728x90

 


bite may cause local and systemic effects. Local effects

include pain, swelling, bruising, and tender enlargement of

regional lymph nodes. Systemic effects include early

anaphylactic symptoms (transient hypotension with

syncope, angioedema, urticaria, abdominal colic, diarrhoea,

and vomiting), with later persistent or recurrent

hypotension, ECG abnormalities, spontaneous systemic

bleeding, coagulopathy, adult respiratory distress syndrome,

and acute renal failure. Fatal envenoming is rare but the

potential for severe envenoming must not be

underestimated.

Early anaphylactic symptoms should be treated with

adrenaline/epinephrine p. 222. Indications for european

viper snake venom antiserum p. 1371 treatment include

systemic envenoming, especially hypotension, ECG

abnormalities, vomiting, haemostatic abnormalities, and

marked local envenoming such that after bites on the hand

or foot, swelling extends beyond the wrist or ankle within

4 hours of the bite. For those patients who present with

clinical features of severe envenoming (e.g. shock, ECG

abnormalities, or local swelling that has advanced from the

foot to above the knee or from the hand to above the elbow

within 2 hours of the bite), a higher initial dose of the

european viper snake venom antiserum is recommended; if

symptoms of systemic envenoming persist contact the

National Poisons Information Service.

Adrenaline/epinephrine injection must be immediately to

hand for treatment of anaphylactic reactions to the european

viper snake venom antiserum.

European viper snake venom antiserum is available for

bites by certain foreign snakes and spiders, stings by

scorpions and fish. For information on identification,

management, and for supply in an emergency, telephone the

National Poisons Information Service. Whenever possible

the TOXBASE entry should be read, and relevant

information collected, before telephoning the National

Poisons Information Service.

Insect stings

Stings from ants, wasps, hornets, and bees cause local pain

and swelling but seldom cause severe direct toxicity unless

many stings are inflicted at the same time. If the sting is in

the mouth or on the tongue local swelling may threaten the

upper airway. The stings from these insects are usually

treated by cleaning the area with a topical antiseptic. Bee

stings should be removed as quickly as possible.

Anaphylactic reactions require immediate treatment with

intramuscular adrenaline/epinephrine; self-administered

intramuscular adrenaline/epinephrine (e.g. EpiPen ®) is the

best first-aid treatment for patients with severe

hypersensitivity. An inhaled bronchodilator should be used

for asthmatic reactions, see also the management of

anaphylaxis. A short course of an oral antihistamine or a

topical corticosteroid may help to reduce inflammation and

relieve itching. A vaccine containing extracts of bee and

wasp venom can be used to reduce the risk of anaphylaxis

and systemic reactions in patients with systemic

hypersensitivity to bee or wasp stings.

Marine stings

The severe pain of weeverfish (Trachinus vipera) and

Portuguese man-o’-war stings can be relieved by immersing

the stung area immediately in uncomfortably hot, but not

scalding, water (not more than 45° C). People stung by

jellyfish and Portuguese man-o’-war around the UK coast

should be removed from the sea as soon as possible.

Adherent tentacles should be lifted off carefully (wearing

gloves or using tweezers) or washed off with seawater.

Alcoholic solutions, including suntan lotions, should not be

applied because they can cause further discharge of stinging

hairs. Ice packs can be used to reduce pain.

Other poisons

Consult either the National Poisons Information Service day

and night or TOXBASE.

The National Poisons Information Service (Tel: 0344

892 0111) will provide specialist advice on all aspects of

poisoning day and night.

1 Active elimination from the

gastro-intestinal tract

ANTIDOTES AND CHELATORS › INTESTINAL

ADSORBENTS

Charcoal, activated

l INDICATIONS AND DOSE

Reduction of absorption of poisons in the gastro-intestinal

system

▶ BY MOUTH

▶ Neonate: 1 g/kg.

▶ Child 1 month–11 years: 1 g/kg (max. per dose 50 g)

▶ Child 12–17 years: 50 g

▶ Adult: 50 g

Active elimination of poisons

▶ BY MOUTH

▶ Neonate: 1 g/kg every 4 hours, dose may be reduced and

the frequency increased if not tolerated, reduced dose

may compromise efficacy.

▶ Child 1 month–11 years: 1 g/kg every 4 hours (max. per

dose 50 g), dose may be reduced and the frequency

increased if not tolerated, reduced dose may

compromise efficacy

▶ Child 12–17 years: Initially 50 g, then 50 g every 4 hours,

reduced if not tolerated to 25 g every 2 hours,

alternatively 12.5 g every 1 hour, reduced dose may

compromise efficacy

▶ Adult: Initially 50 g, then 50 g every 4 hours, reduced if

not tolerated to 25 g every 2 hours, alternatively 12.5 g

every 1 hour, reduced dose may compromise efficacy

Accelerated elimination of teriflunomide

▶ BY MOUTH USING GRANULES

▶ Adult: 50 g every 12 hours for 11 days

Accelerated elimination of leflunomide (washout

procedure)

▶ BY MOUTH USING GRANULES

▶ Adult: 50 g 4 times a day for 11 days

l UNLICENSED USE

▶ In adults Activated charcoal doses in BNF may differ from

those in product literature.

l CAUTIONS Comatose patient (risk of aspiration—ensure

airway is protected). drowsy patient (risk of aspiration—

ensure airway protected).reduced gastrointestinal

motility (risk of obstruction)

l SIDE-EFFECTS Bezoar. constipation . diarrhoea . gastrointestinal disorders

l DIRECTIONS FOR ADMINISTRATION Suspension or

reconstituted powder may be mixed with soft drinks (e.g.

caffeine-free diet cola) or fruit juices to mask the taste.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Oral suspension

▶ Charcodote (Teva UK Ltd)

Activated charcoal 200 mg per 1 ml Charcodote 200mg/ml oral

suspension sugar-free | 250 ml p £11.88

1366 Active elimination from the gastro-intestinal tract BNF 78

Emergency treatment of poisoning

16

Granules

▶ Carbomix (Kent Pharmaceuticals Ltd)

Activated charcoal 813 mg per 1 gram Carbomix 81.3% granules

sugar-free | 50 gram p £11.90

2 Chemical toxicity

2.1 Cyanide toxicity

ANTIDOTES AND CHELATORS

Dicobalt edetate

l INDICATIONS AND DOSE

Severe poisoning with cyanides

▶ BY INTRAVENOUS INJECTION

▶ Child: Consult the National Poisons Information

Service

▶ Adult: 300 mg, to be given over 1 minute (or 5 minutes

if condition less serious), dose to be followed

immediately by 50 mL of glucose intravenous infusion

50%; if response inadequate a second dose of both may

be given, but risk of cobalt toxicity

l CAUTIONS Owing to toxicity to be used only for definite

cyanide poisoning when patient tending to lose, or has

lost, consciousness

l SIDE-EFFECTS Reflex tachycardia . vomiting

l EXCEPTIONS TO LEGAL CATEGORY Prescription only

medicine restriction does not apply where administration

is for saving life in emergency.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Solution for injection

▶ Dicobalt edetate (Non-proprietary)

Dicobalt edetate 15 mg per 1 ml Dicobalt edetate 300mg/20ml

solution for injection ampoules | 6 ampoule P £117.20 DT =

£117.20

Sodium nitrite 16-Mar-2018

l INDICATIONS AND DOSE

Poisoning with cyanides (used in conjunction with sodium

thiosulfate)

▶ BY INTRAVENOUS INJECTION

▶ Child: Consult the National Poisons Information

Service

▶ Adult: 300 mg

l SIDE-EFFECTS Arrhythmias . dizziness . headache . hypotension . palpitations

l EXCEPTIONS TO LEGAL CATEGORY Prescription only

medicine restriction does not apply where administration

is for saving life in emergency.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Solution for injection

▶ Sodium nitrite (Non-proprietary)

Sodium nitrite 30 mg per 1 ml Sodium nitrite 300mg/10ml solution

for injection vials | 1 vial P s

Sodium thiosulfate 16-Mar-2018

l INDICATIONS AND DOSE

Poisoning with cyanides

▶ BY INTRAVENOUS INJECTION

▶ Child: Consult the National Poisons Information

Service

▶ Adult: 12.5 g, to be given over 10 minutes, dose may be

repeated in severe cyanide poisoning

DOSE EQUIVALENCE AND CONVERSION

▶ 12.5 g equates to 50 mL of a 25% solution or 25 mL of a

50% solution.

l EXCEPTIONS TO LEGAL CATEGORY Prescription only

medicine restriction does not apply where administration

is for saving life in emergency.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug. Forms available

from special-order manufacturers include: solution for

injection

Solution for injection

▶ Sodium thiosulfate (Non-proprietary)

Sodium thiosulfate 250 mg per 1 ml Sodium thiosulfate 12.5g/50ml

solution for injection vials | 1 vial P s

2.2 Organophosphorus toxicity

Other drugs used for Organophosphorus toxicity Atropine

sulfate, p. 1334

ANTIDOTES AND CHELATORS

Pralidoxime chloride

l INDICATIONS AND DOSE

Adjunct to atropine in the treatment of poisoning by

organophosphorus insecticide or nerve agent

▶ BY INTRAVENOUS INFUSION

▶ Child: Initially 30 mg/kg, to be given over 20 minutes,

followed by 8 mg/kg/hour; maximum 12 g per day

▶ Adult: Initially 30 mg/kg, to be given over 20 minutes,

followed by 8 mg/kg/hour; maximum 12 g per day

l UNLICENSED USE Pralidoxime chloride doses may differ

from those in product literature.

▶ In children Licensed for use in children (age range not

specified by manufacturer).

l CONTRA-INDICATIONS Poisoning with carbamates . poisoning with organophosphorus compounds without

anticholinesterase activity

l CAUTIONS Myasthenia gravis

l SIDE-EFFECTS Dizziness . drowsiness . headache . hyperventilation . muscle weakness . nausea .tachycardia . visual impairment

l RENAL IMPAIRMENT Use with caution.

l DIRECTIONS FOR ADMINISTRATION The loading dose may

be administered by intravenous injection (diluted to a

concentration of 50 mg/mL with water for injections) over

at least 5 minutes if pulmonary oedema is present or if it is

not practical to administer an intravenous infusion.

▶ In children For intravenous infusion, reconstitute each vial

with 20 mL Water for Injections, then dilute to a

concentration of 10–20 mg/mL with Sodium Chloride

0.9%.

l PRESCRIBING AND DISPENSING INFORMATION Available

from designated centres for organophosphorus insecticide

poisoning or from the National Blood Service (or Welsh

BNF 78 Organophosphorus toxicity 1367

Emergency treatment of poisoning

16

Ambulance Services for Mid West and South East Wales)—

see TOXBASE for list of designated centres).

l EXCEPTIONS TO LEGAL CATEGORY Prescription only

medicine restriction does not apply where administration

is for saving life in emergency.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Powder for solution for injection

▶ Pralidoxime chloride (Imported (United States))

Pralidoxime chloride 1 gram Protopam Chloride 1g powder for

solution for injection vials | 6 vial P s

3 Drug toxicity

3.1 Benzodiazepine toxicity

ANTIDOTES AND CHELATORS ›

BENZODIAZEPINE ANTAGONISTS

Flumazenil 23-Jul-2018

l INDICATIONS AND DOSE

Reversal of sedative effects of benzodiazepines in

anaesthesia and clinical procedures

▶ BY INTRAVENOUS INJECTION

▶ Adult: 200 micrograms, dose to be administered over

15 seconds, then 100 micrograms every 1 minute if

required; usual dose 300–600 micrograms; maximum

1 mg per course

Reversal of sedative effects of benzodiazepines in

intensive care

▶ BY INTRAVENOUS INJECTION

▶ Adult: 300 micrograms, dose to be administered over

15 seconds, then 100 micrograms every 1 minute if

required; maximum 2 mg per course

Reversal of sedative effects of benzodiazepines in

intensive care (if drowsiness recurs after injection)

▶ INITIALLY BY INTRAVENOUS INFUSION

▶ Adult: 100–400 micrograms/hour, adjusted according

to response, alternatively (by intravenous injection)

300 micrograms, adjusted according to response

IMPORTANT SAFETY INFORMATION

Flumazenil should only be administered by, or under the

direct supervision of, personnel experienced in its use.

l CONTRA-INDICATIONS Life-threatening condition (e.g.

raised intracranial pressure, status epilepticus) controlled

by benzodiazepines

l CAUTIONS Avoid rapid injection following major surgery . avoid rapid injection in high-risk or anxious patients . benzodiazepine dependence (may precipitate withdrawal

symptoms). elderly . ensure neuromuscular blockade

cleared before giving . head injury (rapid reversal of

benzodiazepine sedation may cause convulsions) . history

of panic disorders (risk of recurrence). prolonged

benzodiazepine therapy for epilepsy (risk of convulsions). short-acting (repeat doses may be necessary—

benzodiazepine effects may persist for at least 24 hours)

l SIDE-EFFECTS

▶ Common or very common Anxiety . diplopia . dry mouth . eye disorders . flushing . headache . hiccups . hyperhidrosis . hyperventilation . hypotension . insomnia . nausea . palpitations . paraesthesia . speech disorder.tremor. vertigo . vomiting

▶ Uncommon Abnormal hearing . arrhythmias . chest pain . chills . cough . dyspnoea . nasal congestion . seizure (more

common in patients with epilepsy)

▶ Frequency not known Withdrawal syndrome

l PREGNANCY Not known to be harmful.

l BREAST FEEDING Avoid breast-feeding for 24 hours.

l HEPATIC IMPAIRMENT Manufacturer advises caution (risk

of increased half-life).

Dose adjustments Manufacturer advises cautious dose

titration.

l DIRECTIONS FOR ADMINISTRATION For continuous

intravenous infusion, dilute with Glucose 5% or Sodium

Chloride 0.9%.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Solution for injection

▶ Flumazenil (Non-proprietary)

Flumazenil 100 microgram per 1 ml Flumazenil

500micrograms/5ml solution for injection ampoules | 5 ampoule P £72.46 (Hospital only) | 5 ampoule P £65.50–

£70.00 | 10 ampoule P £140.00

3.2 Digoxin toxicity

ANTIDOTES AND CHELATORS › ANTIBODIES

Digoxin-specific antibody

l INDICATIONS AND DOSE

Treatment of known or strongly suspected lifethreatening digoxin toxicity associated with ventricular

arrhythmias or bradyarrhythmias unresponsive to

atropine and when measures beyond the withdrawal of

digoxin and correction of any electrolyte abnormalities

are considered necessary

▶ BY INTRAVENOUS INFUSION

▶ Child: Serious cases of digoxin toxicity should be

discussed with the National Poisons Information

Service (consult product literature)

▶ Adult: Serious cases of digoxin toxicity should be

discussed with the National Poisons Information

Service (consult product literature)

l DIRECTIONS FOR ADMINISTRATION

▶ In adults For intravenous infusion (DigiFab ®), given

intermittently in Sodium chloride 0.9%. Reconstitute with

water for injections (4 mL/vial), then dilute with infusion

fluid and give over 30 minutes.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Powder for solution for infusion

▶ DigiFab (BTG International Ltd)

Digoxin-specific antibody fragments 40 mg DigiFab 40mg powder

for solution for infusion vials | 1 vial P £750.00 (Hospital only)

3.3 Heparin toxicity

ANTIDOTES AND CHELATORS

Protamine sulfate

l INDICATIONS AND DOSE

Overdosage with intravenous injection of unfractionated

heparin

▶ BY INTRAVENOUS INJECTION

▶ Adult: Dose to be administered at a rate not exceeding

5 mg/minute, 1 mg neutralises 80–100 units heparin

when given within 15 minutes; if longer than 15 minute

since heparin, less protamine required (consult product

1368 Drug toxicity BNF 78

Emergency treatment of poisoning

16

No comments:

Post a Comment

اكتب تعليق حول الموضوع

mcq general

 

Search This Blog